Who owns Evolent Health, Inc.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of EVH from SEC Form 13F filings across 198 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-06-30 reporting period, 198 institutions disclosed 112.3M shares of Evolent Health, Inc. worth $608.3M — about 99.8% of shares outstanding; the largest disclosed holder is BlackRock, Inc.. Source: SEC Form 13F filings, parsed by EvidInvest.
198
13F holders
$608.3M
value, 2026 filers
99.8%
of shares outstanding (112.3M sh)
39
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30 · % of fund = share of the manager's own book · % of co. = share of EVH's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | BlackRock, Inc. | 14.8M | $80.3M | 0.0% | 13.2% | +36.1% |
| 2 | CADIAN CAPITAL MANAGEMENT, LP | 10.8M | $58.6M | 4.4% | 9.6% | 0.0% |
| 3 | MORGAN STANLEY | 9.0M | $48.6M | 0.0% | 8% | -1.2% |
| 4 | UBS Group AG | 6.2M | $33.8M | 0.0% | 5.5% | -23.4% |
| 5 | Rubicon Founders LLC | 5.8M | $31.5M | 16.0% | 5.2% | 0.0% |
| 6 | Engaged Capital LLC | 5.6M | $30.2M | 9.2% | 4.9% | 0.0% |
| 7 | D. E. Shaw & Co., Inc. | 5.1M | $27.7M | 0.0% | 4.5% | -6.0% |
| 8 | VANGUARD CAPITAL MANAGEMENT LLC | 4.8M | $26.0M | 0.0% | 4.3% | -1.6% |
| 9 | MARSHALL WACE, LLP | 3.4M | $18.5M | 0.0% | 3% | +334.8% |
| 10 | Nuveen, LLC | 3.1M | $17.0M | 0.0% | 2.8% | +1081.3% |
| 11 | GEODE CAPITAL MANAGEMENT, LLC | 2.9M | $15.7M | 0.0% | 2.6% | +10.9% |
| 12 | Rock Springs Capital Management LP | 2.5M | $13.6M | 0.7% | 2.2% | -6.5% |
| 13 | STATE STREET CORP | 2.5M | $13.3M | 0.0% | 2.2% | -7.0% |
| 14 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 2.1M | $11.6M | 0.0% | 1.9% | +9.3% |
| 15 | GOLDMAN SACHS GROUP INC | 1.7M | $9.5M | 0.0% | 1.6% | -21.9% |
| 16 | Rock Point Advisors, LLC | 1.7M | $9.3M | 2.3% | 1.5% | -3.7% |
| 17 | JACOBS LEVY EQUITY MANAGEMENT, INC | 1.6M | $8.7M | 0.0% | 1.4% | +162.5% |
| 18 | KENNEDY CAPITAL MANAGEMENT LLC | 1.6M | $8.5M | 0.2% | 1.4% | -1.9% |
| 19 | VANGUARD PORTFOLIO MANAGEMENT LLC | 1.3M | $7.3M | 0.0% | 1.2% | +44.8% |
| 20 | HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUNDNEW | 1.3M | $6.9M | 0.0% | 1.1% | new |
| 21 | TWO SIGMA INVESTMENTS, LP | 1.3M | $6.8M | 0.0% | 1.1% | +45.0% |
| 22 | NORTHERN TRUST CORP | 1.0M | $5.4M | 0.0% | 0.9% | +9.4% |
| 23 | Hudson Bay Capital Management LP | 913,109 | $4.9M | 0.0% | 0.8% | -30.6% |
| 24 | BANK OF AMERICA CORP /DE/ | 875,398 | $4.7M | 0.0% | 0.8% | +211.7% |
| 25 | BNP PARIBAS FINANCIAL MARKETS | 860,358 | $4.7M | 0.0% | 0.8% | -3.5% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.